Abstract:Abstract Background: Previous studies have demonstrated that PCSK9 was constitutively expressed in osteoclast precursors and played an important role in bone metabolism in periodontitis disease. But the function of PCSK9 in the osteogenesis of hBMSCs and specific mechanism still remains unknown. In this study, we aim to explore the function and mechanism of PCSK9 on regulating osteogenic differentiation and osteoclastic differentiation.Methods: The osteogenic effects of endogenous and exogenous PCSK9 on hBMSCs were performed, the effect on osteoclastic differentiation of mBMM too. A CCK-8 was used to assess the effect of PCSK9 on the proliferation of hBMSCs. qRT-PCR and Western blotting analysis were conducted to determine the expression of target genes and proteins. ALP, ARS staining were used to evaluate osteoblasts, the trap staining was used to evaluate osteoclasts. In vivo experiment, we constructed a femoral bone defect model, and injected Adeno associated virus at defect site. Radiographic analysis and histological evaluation were conducted to evaluate the union effect of PCSK9 at bone defect site. Student’s t test was used between two groups, one-way ANOVA or Bonferroni’s post-hoc test was used more than two groups, depending on the distribution of the tested population.Result: In vitro experiment, low dose exogenous and overexpress endogenous PCSK9 could enhance hBMSCs osteogenic differentiation via ERK signaling pathway, and knockdown PCSK9 would reduce this influence. The promoting effect could be weaken by ERK inhibitor PD98059 with an appropriate concentration. All of which was confirmed by q-PCR, Western blotting and immunofluorescence outcome. Besides, the ALP staining, ARS staining results prove that it could raise ALP activity and mineral deposits formation. But low dose PCSK9 has no obvious effect on osteoclastic differentiation. In vivo experiment, the radiographic, histological result prove overexpress PCSK9 could accelerate bone defect union. Conclusion: In summarize, PCSK9 could promote osteogenic differentiation via ERK pathway and has no effect on osteoclast differentiation. The vivo and vitro experiments outcomes indicate that it may be a novel target for treating bone defect union.

Cathepsin K deficiency promotes alveolar bone regeneration by promoting jaw bone marrow mesenchymal stem cells proliferation and differentiation via glycolysis pathway

Cathepsin K inhibition alleviates periodontal bone resorption by promoting type H vessel formation through PDGF‐BB/PDGFR‐β axis

Autophagy was involved in tumor necrosis factor--inhibited osteogenic differentiation of murine calvarial osteoblasts through Wnt/-catenin pathway

Autophagy was involved in tumor necrosis factor-α-inhibited osteogenic differentiation of murine calvarial osteoblasts through Wnt/β-catenin pathway.

Knockout and Double Knockout of Cathepsin K and Mmp9 Reveals a Novel Function of Cathepsin K As a Regulator of Osteoclast Gene Expression and Bone Homeostasis

Elevated Expression of Cathepsin K in Periodontal Ligament Fibroblast by Inflammatory Cytokines Accelerates Osteoclastogenesis via Paracrine Mechanism in Periodontal Disease

The Role of Cathepsin K in Oral and Maxillofacial Disorders

PCSK9 promotes osteogenic differentiation via ERK pathway and has no effect on osteoclast differentiation

Effects of Cathepsin K on Emdogain-induced Hard Tissue Formation by Human Periodontal Ligament Stem Cells.

Distribution of Cathepsin K in Late Stage of Tooth Germ Development and Its Function in Degrading Enamel Matrix Proteins in Mouse

Dental Abnormalities Caused by Novel Compound Heterozygous CTSK Mutations.

Cathepsin K+ Non-Osteoclast Cells in the Skeletal System: Function, Models, Identity, and Therapeutic Implications

Cathepsin K‐Positive Cell Lineage Promotes In Situ Dentin Formation Controlled by Nociceptive Sonic Hedgehog

Spp1 Secreted by Macrophages Impairs Osteogenic Ability of Ctsk+Fmod+ Periosteal Cells in Jaw Bone

Alpha-ketoglutarate Promotes Alveolar Bone Regeneration by Modulating M2 Macrophage Polarization

CK1ε drives osteogenic differentiation of bone marrow mesenchymal stem cells via activating Wnt/β-catenin pathway

Postnatal Deletion of -catenin in Preosteoblasts Regulates Global Energy Metabolism through Increasing Bone Resorption and Adipose Tissue Fibrosis

Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence.

Superior CKIP-1 Sensitivity of Orofacial Bone-Derived Mesenchymal Stem Cells in Proliferation and Osteogenic Differentiation Compared to Long Bone-Derived Mesenchymal Stem Cells

METTL3 Modulates Ctsk+ Lineage Supporting Cranial Osteogenesis via Hedgehog

The Silencing of Cathepsin K Used in Gene Therapy for Periodontal Disease Reveals the Role of Cathepsin K in Chronic Infection and Inflammation.